<div id="readability-page-1"><div><p><span>Ring Christine Officer of Nurix Therapeutics Inc [NRIX] filed a Form 4 on December 18, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>12/18/25</span></td><td><span>Planned Exercise(1)(2)</span></td><td><span>3,760</span></td><td><span>$1.86</span></td><td><span>$6,994</span></td></tr><tr><td><span>12/18/25</span></td><td><span>Planned Sale(2)</span></td><td><span>3,760</span></td><td><span>$17.90</span></td><td><span>$67,314</span></td></tr></tbody></table></div><p><span>Ending Holdings: 50,897 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Exercised 3.8 years before expiration date.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

NRIX

<p>Christine Ring, an officer at Nurix Therapeutics Inc, filed a Form 4 with the SEC on December 18, 2025, disclosing a planned exercise and sale of 3,760 shares at $1.86 and $17.90 respectively, totaling $67,314. The transactions were executed under a prearranged trading plan (10b5-1). Ring's ending holdings are 50,897 shares.</p>

Officer Ring Sells 3,760 ($67.3K) Of Nurix Therapeutics Inc [NRIX]